Extended Data Fig. 1
From: Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Structures of senaparib, olaparib, niraparib, and rucaparib.
Extended Data Fig. 1 | Nature Medicine
From: Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Structures of senaparib, olaparib, niraparib, and rucaparib.
